The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function

By sjmartinez • February 15, 2023

Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-González G, Membrives C, Díaz-Tocados JM, Martínez-Moreno JM, Torralbo AI, Herencia C, Rodríguez-Ortiz ME, López-Baltanás R, Richards WG, Felsenfeld A, Almadén Y, Martin-Malo A, Ureña J, Santamaría R, Soriano S, Rodríguez M, Muñoz-Castañeda JR. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220. PMID: 35867864; PMCID: PMC9923714.

Tags: arterial stiffness, Chronic kidney disease, FGF23, microRNA, Nephrology, Publications, vascular smooth muscle cells

Thrombocytopenia Occurrence With NxStage vs. Prismaflex Continuous Renal Replacement Systems

Khorsan R. Thrombocytopenia Occurrence With NxStage vs. Prismaflex Continuous Renal Replacement Systems. Cureus. 2025 Dec 19;17(12):e99659. doi: 10.7759/cureus.99659. PMID: 41561238; PMCID: PMC12812480.

Kappa-Restricted IgA Nephropathy Treated Successfully With Targeted-Release Budesonide

Neinast M, Zuckerman JE, Khorsan R, Nobakht N, Kamgar M, Sarkar M, Kamal F, Arman F. Kappa-Restricted IgA Nephropathy Treated Successfully With Targeted-Release Budesonide. Kidney[...]

Reuse of a Living Donor Kidney: A Case Study

Yin Y, Prewitt F, Nguyen J, Tao J, Pham PT, Kendrick E, Nassiri N, Veale JL, Reed EF, Hickey MJ. Reuse of a Living Donor[...]